Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Really just wanted to play a bounce but I think I’m over it now. Too much risk for me for the next couple weeks. Gonna wait, enjoy the weekend!!
Can’t argue with that..and the MC is out of whack imo
Hahaha....me to my friend, me too.
Scratching my head right now with the market today. I have a feeling next week I’ll be saying damn I should bought last Friday.
Lol Mcbrutal....I’m hungry now.
Ides of March are here by the looks of it. Liquidity dropping for the next couple weeks. Was playing the cup and handle on Khiron today but might have to bail on that too
Fugly market today wowza!
Nice DD sir. That comparison with VFF says it all...yup scary to think the MC are the same yikes.
BBM is interesting but at what point is this over extended on the chart? It’s had a couple big days. On the radar for sure.
I seen that... spread it was 10.37, I put a bid in at 10.38 and it moved back up to 10.50
Yeah I agree, this is still in the infancy stage really. It’s got a long ways to go and red tape to cut through just trying to play the chart but it’s when I get greedy I usually get burned. So on second thought I’ll watch from the sidelines here for a bit.
Summary of estimated completion dates: Timeline Summary See below for a summary of the estimated timeline for the completion of Phase 1: Base Building: Completed. Health Canada Attestation Video: February 7 and 8, 2019. Building Occupancy: February 28, 2019. Flowering Rooms 1 and 2 (Partial): March 15, 2019. Cultivation License: Expected Q1, 2019. Flowering Rooms 3 8: December 31, 2019. This timeline is subject to change and is based on current internal estimates.
Let’s see if that line holds on your chart 10.40 ish. Might have to place a wager.
Awesome thanks for the charts, love em!
SUGR steaming ahead of approval from HC.
Almost time for re entry to PCLO.
Blueberries weeeeeeee nice call on that one, it’s a beast! (Not in that one)
Yeah for sure, the risk was there and wasn’t completely secure in my entry. Tight stop was in order.
Sugr should be cultivation license by eom.
Yeah got stopped out this morning
What a beauty. On the hourly it consolidates moves up, and repeats. Let’s see a strong close $pclo$
I hear ya, patience is tough in this choppy market right now. Agreed if it comes down to that second line I’ll be waiting.
Nice news $PCLO.
Considering adding to this one too.....maybe this aft.
Not worried about Khiron lil consolidation...gonna give it a couple days.
Another half million hey, good sign!
Well if they are buying maybe retail should be adding...
No I did look up blueberries briefly but looked like it had it’s spike already. Nice call sir.
Nice! Liking the chart not liking the MC let’s see how today plays out.
Haven’t followed that board for awhile, which I should be. Thanks for the link. Yeah I didn’t find the % they own in the link.
As for the other one...only a matter of time before they pick it up.
TORONTO – March 18, 2019 – Horizons ETFs Management (Canada) Inc. (“Horizons ETFs”) has completed the quarterly rebalance of the constituent holdings of the Horizons Marijuana Life Sciences Index ETF (“HMMJ:TSX”).
HMMJ is the world’s first ETF offering direct exposure to North American-listed securities that are involved with marijuana bioengineering and production. Once again, the ETF has added additional companies to its portfolio as more firms have become eligible for inclusion in its underlying index – the North American Marijuana Index.
The HMMJ portfolio recently expanded to include the following constituents:
Company Name:
PharmaCielo Ltd.
Ticker PCLO
Exchange TSX Venture Exchange
Hmmm never heard of them. Have to check it out...thanks.
MJ index up today:
Sea of green today.
674.34 10.49
Constituents20
% Change1.58%
Open Price664.12
Total Volume77.52 m
52 Week High906.87
52 Week Low403.95
$PCLO
Analysts at GMP just initiated coverage on PharmaCielo Ltd. (PHCEF)(PCLO) with a Buy rating and a price target of C$12. They also note that PCLO is the best pure-play on the global CDB market. “We consider PCLO to be the most advanced Colombian licensed producer currently, providing a ~6–18 month first-mover advantage over nearly all Colombian competitors. In addition, with CBD extract capacity expected to reach ~17 tonnes in 2019, we believe this qualifies PCLO as the largest international publicly-traded producer.”
“With favorable Colombian regulations, we estimate PCLO could have CBD yields ~250x–300x higher than those available to global peers. We believe PCLO could achieve CBD extract production costs as low as ~$0.15–0.25/gram, potentially the lowest globally.”
“The tortilla has been turned
around” lol
https://midasletter.com/2019/01/55th-mexican-president-khiron-life-sciences-corp-cvekhrn-director-vicente-fox-khirons-corporate-strategy/
Or alternatively one COULD JUST "go by" what the share prices are doing
Which is generally what I do - since I'm quite useless at "researching"
You seem to be quite brilliant at the “research part” imo.
Been off the grid all day, have to get back in the saddle tomorrow.
Good stuff Nowwhat!!
Loving it!
Dixie Khiron JV:
Dixie Khiron JV Corp. formally established to bring Dixie Brands portfolio of cannabis-infused products to Latin America
Dixie and Khiron are 50/50 JV co-owners JV introduces Khiron's Kuida® brand to the U.S. market, with special focus on the Hispanic population of almost 60 million
JV has full access to Dixie's portfolio of more than 100 SKUs sold over the past 9 years in world's most mature cannabis markets
Dixie-Khiron to enjoy first-mover advantage in Latin American market of 620 million people
LatAm cannabis market estimated to reach $12 billion by 2028 (source: Prohibition Partners)
Latin America is among the world's fastest-growing cannabis markets. According to Prohibition Partners, cannabis spending in the region is expected to reach US$12 billion by 2028, and Quintiles IMS estimates that there are approximately 68 million potential patients in Latin America that could benefit from medical cannabis.
Khiron will be positioned in markets which collectively represent more than 430 million of the total Latin American population of 620 million people.
Country Population
(millions)
Brazil 1 208
Mexico 124
Colombia 48
Peru 32
Chile 18
Uruguay 1 3
https://www.ftmig.com/cannabis/dixie-brands-and-khiron-life-sciences-to-bring-more-than-100-market-proven-products-to-the-latin-american-cannabis-market/
By far the most recognizable brand in cannabis edibles in the US for nearly a decade, Dixie has also become a market leader in the industry’s embryonic consumer-packaged goods (CPG) sector. Now it’s Khiron’s turn to shine.
image: https://stockhouse.com/media/news-images/Independent-Reports/khiron01.png
Click to enlarge
We have bee
Read more at https://stockhouse.com/news/newswire/2019/02/08/why-market-loves-khiron-s-dream-deal#KyQwjdEk06lshB6C.99
We Both have skin in the game now, thanks for that btw. Have to check out both companies this weekend. Have shares in both, you have better entries on PCLO than me but it’s all good. You’ve been a great source of info!
I’m out, enjoy the weekend.
Lmao, too funny I just picked some up myself. Patience is not my strong suit.
Good info from that Midas letter. Thanks mate!
Wow you on a roll. 89 mil o/s nice and small SS. I’ll have to check it out thanks for the info. Vicente Fox ex prez on BOD.
Looks like they have a few South American countries on board. Check this out later....
Gotta finish my route first lol
Just joined you at the red dot. Looking good. This one is totally off most people’s radar but that’s ok
Damn.. wasn’t paying attention. Looks like your $9’s are in the money. Your chart is looking pretty accurate so far, nice!
5.5 Mil flower capacity...insane. I would have to almost see it to believe or to get the scale of it.
Yup I am, your friend works in better conditions than me though being in YYC.
At least you have a stater and some skin in the game...I’m patiently waiting...let’s see what tomorrow brings and the overall market.
We are so exited to open Trulieve Miami Gardens tomorrow! Join us as we celebrate our 25th location with 25% off all purchases, free swag, food and more at 18350 NW 47th Ave
— Trulieve (@Trulieve) March 13, 2019
Miami Gardens, FL 33055 pic.twitter.com/BUQtRd492a
Yeah I was wondering the same thing about the one pic. Didn’t see it on the investor presentation. The actual presentation on their website is very good, a few good nuggets in there. Thanks for the charts bud, I appreciate it. Looking to steal some cheap here but gonna let it settle first.
Solid! Thanks for the info. Have to do a little more digging but looking like I will join you.
Shares Outstanding:94.8 million
Recent Price:$8.43
Fully Diluted:110.5 million
Market Cap: 931.5 million
Cash:$41.4 million
Insider Ownership:~20%
Now what, what is going on here?
Looks interesting. Found the needle in the haystack....?
From Seeking Alpha(which means little)
On a 10 times revenue valuation basis only on domestic market, a conservative valuation for Pharmacielo would stand at 2.5B, resulting in a 25$/shares price target for 2020.
Since the company is starting sales in 2019 and still has market confirmations to provide, we would apply a 40% discount to price in such risk.
Therefore, our current price target for the stock is 15$ per share.
nice news!
HEXO Corp to acquire Newstrike Brands Ltd.
March 13, 2019 06:30 ET | Source: HEXO Corp.
multilang-release
With this acquisition, HEXO will add 470,000 sq. ft. in production space when completed, additional public and private retail channels, and a branding relationship with members of The Tragically Hip
Over $400 million of pro forma net annual revenue ending July 2020 expected by HEXO following acquisition
GATINEAU, Quebec and TORONTO, March 13, 2019 (GLOBE NEWSWIRE) -- HEXO Corp ("HEXO") (TSX: HEXO; NYSE-A: HEXO) and Newstrike Brands Ltd. ("Newstrike") (TSX-V: HIP) are pleased to announce that they have entered into a definitive arrangement agreement (the "Arrangement Agreement") under which HEXO will acquire, by way of a plan of arrangement under the Business Corporations Act (Ontario), all of Newstrike’s issued and outstanding common shares in an all-share transaction valued at approximately $263 million (the "Transaction").
Under the terms of the Arrangement Agreement, Newstrike shareholders will receive 0.06332 of a HEXO common share in exchange for each Newstrike common share held.
The Transaction has been unanimously approved by the board of directors of each of HEXO and Newstrike, and Newstrike’s board of directors recommends that its shareholders vote in favour of the Transaction.
Transaction Highlights
Capacity boost with state-of-the-art cultivation infrastructure: The Transaction gives HEXO the capacity to produce approximately 150,000 kg of high-quality cannabis annually. The Transaction also provides HEXO access to four cutting-edge production campuses totalling close to 1.8 million sq. ft. of near-term cultivation space and diversified growing and production techniques. This is in addition to HEXO’s 579,000 sq. ft. facility for a manufacturing and product development centre of excellence in Belleville, Ontario.
Diversified domestic market penetration: Combined, HEXO and Newstrike have established distribution agreements in 8 provinces including Ontario, Quebec, British Columbia, Alberta, Saskatchewan, Manitoba, Nova Scotia, and Prince Edward Island, allowing broad consumer access to HEXO’s products across Canada.
Premium indoor facility: Newstrike’s licensed indoor facility provide HEXO with access to diversified growing techniques and positions HEXO for flexibility for international exports as global cannabis markets continue to open.
Accretive synergies: The combined entity is estimated to realize annual synergies of $10 million, allowing HEXO to operate more efficiently with a commitment to continued excellence.
“We're thrilled to welcome the Newstrike team into the HEXO family. Jay Wilgar (CEO of Newstrike) and his team have built incredible relationships, including teaming up with The Tragically Hip, and they share HEXO’s vision of bringing exceptional branded cannabis experiences to adults everywhere,” said Sebastien St-Louis, CEO and co-founder of HEXO Corp “With Newstrike, we're adding talented employees and infrastructure to take HEXO to the next level on our journey to become one of the largest cannabis companies in the world. We're extremely proud of our record of execution, and today are committing to achieving over $400 million in net revenue in 2020.”
“This is the most compelling combination we see in the Canadian cannabis sector. Our strength in Ontario and English Canada clearly complements HEXO’s strong position in Quebec and creates an industry leader. The combination will deliver meaningful synergies, a stronger financial position with increased flexibility, and will position the combined company to meet growing consumer demand on a national basis. I believe this transaction is beneficial to our shareholders, customers, and employees. We look forward to working closely with the leadership team to complete this transaction," added Jay Wilgar, CEO of Newstrike.
Additional Transaction Details
The Transaction will require approval by (i) at least 66 2/3% of the votes cast by the shareholders of Newstrike; and (ii) a simple majority of the votes cast by disinterested shareholders of Newstrike, present at a special meeting of Newstrike shareholders. HEXO has entered into irrevocable hard voting support agreements with each of Newstrike’s directors and officers, along with certain other shareholders of Newstrike, representing in aggregate approximately 25% of Newstrike's issued and outstanding common shares.
The Arrangement Agreement includes customary provisions including non-solicitation provisions, subject to the right of Newstrike to accept a superior proposal in certain circumstances, with HEXO having a five business day right to match any such superior proposal for Newstrike. The Arrangement Agreement also provides for a termination fee of $7.5 million payable by Newstrike to HEXO if the Transaction is terminated in certain specified circumstances, as well as a reciprocal $1 million expense reimbursement fee to either party if the Transaction is terminated in certain other specified circumstances.
In addition to Newstrike shareholder approvals, the Transaction is subject to the receipt of certain regulatory court and stock exchange approvals and the satisfaction of other conditions customary in transactions of this nature.
Upon completion of the Transaction, existing HEXO and Newstrike shareholders would own approximately 86% and 14% of the pro forma company, respectively, on a fully diluted basis.
Further information regarding the Transaction will be included in the information circular that Newstrike will prepare, file, and mail in due course to its shareholders in connection with its special meeting to be held to consider the Transaction. The Arrangement Agreement will be filed on the SEDAR profiles of Newstrike and HEXO on the SEDAR website at www.sedar.com.
None of the securities to be issued pursuant to the Arrangement Agreement have been or will be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws, and any securities issued in the Arrangement are anticipated to be issued in reliance upon the exemption from such registration requirements provided by Section 3(a)(10) of the U.S. Securities Act and applicable exemptions under state securities laws. This news release does not constitute an offer to sell or the solicitation of an offer to buy any securities.
Recommendation of Newstrike’s Board
Newstrike’s board of directors has unanimously determined, after receiving the unanimous recommendation of a special committee formed for purposes of the Transaction, and financial and legal advice, that the Transaction is in the best interests of Newstrike and its security holders, and the board of directors unanimously recommends that Newstrike’s shareholders vote in favour of the Transaction.
The board of directors of Newstrike has obtained a fairness opinion from RBC Capital Markets that, as of the date of the opinion, and subject to the assumptions, limitations, and qualifications on which such opinion is based, the consideration to be received pursuant to the Transaction is fair, from a financial point of view, to the Newstrike shareholders.
Advisors and Counsel
RBC Capital Markets is acting as the exclusive financial advisor to Newstrike. Stikeman Elliott LLP is acting as legal counsel to Newstrike. Osler, Hoskin & Harcourt LLP is acting as legal counsel to special committee of the board of directors of Newstrike.
Norton Rose Fulbright Canada LLP is acting as legal counsel to HEXO.
HEXO Financial Outlook
Based on the completion of the Transaction, for fiscal 2020, HEXO estimates net and gross revenues from the sale of cannabis in Canada will be in excess of $400 million and $479 million respectively.
This estimate is based on management’s current views, strategies, expectations, assumptions and forecasts, and has been calculated using accounting policies that are generally consistent with our current accounting policies. The estimate is derived from the expected net revenues from the sale of cannabis and cannabis products in the Canadian market alone. In addition, the estimate excludes the activity of current and future joint ventures, including HEXO’s Truss joint venture, as well as any merger and acquisition activity other than the Transaction.
This estimate is considered a financial outlook under applicable securities laws. The estimate and any other financial outlooks or future-oriented financial information included herein has been approved by management of HEXO as of the date hereof. Such financial outlooks or future-oriented financial information are provided for the purpose of presenting information about management's current expectations and goals relating to the future business of HEXO. Readers are cautioned that actual results may vary materially as a result of a number of risks, uncertainties and other factors, many of which are beyond HEXO’s control. See “Cautionary Note Regarding Forward-Looking Statements”.